Safety profile of miltefosine in the treatment of cutaneous leishmaniasis.
Cutaneous leishmaniasis (CL) is a neglected tropical disease that poses a significant public health challenge in Brazil and worldwide. Miltefosine, the only orally administered drug available for CL, was recently incorporated into Brazil's treatment protocols following recommendations by the World H...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science (PLoS)
2024-01-01
|
| シリーズ: | PLoS ONE |
| オンライン･アクセス: | https://doi.org/10.1371/journal.pone.0315710 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|